In Vitro Immunomodulation of a Whole Blood IFN-γ Release Assay Enhances T Cell Responses in Subjects with Latent Tuberculosis Infection

Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 10; p. e48027
Main Authors Gaur, Rajiv L., Suhosk, Megan M., Banaei, Niaz
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 29.10.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0048027

Cover

Abstract Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.
AbstractList Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. Methods In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. Results In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. Conclusions In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.
Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. Methods In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. Results In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. Conclusions In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.
Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.
Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.
Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.BACKGROUNDActivation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-γ) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity.In vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.METHODSIn vitro immunomodulation of a whole blood IGRA (QuantiFERON®-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls.In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.RESULTSIn vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I:C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-α and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells.In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.CONCLUSIONSIn vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.
Author Banaei, Niaz
Suhosk, Megan M.
Gaur, Rajiv L.
AuthorAffiliation 1 Department of Pathology, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
2 Department of Medicine,Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
3 Clinical Microbiology Laboratory, Stanford Hospital and Clinics, Palo Alto, California, United States of America
Hopital Raymond Poincare - Universite Versailles St. Quentin, France
AuthorAffiliation_xml – name: Hopital Raymond Poincare - Universite Versailles St. Quentin, France
– name: 2 Department of Medicine,Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
– name: 3 Clinical Microbiology Laboratory, Stanford Hospital and Clinics, Palo Alto, California, United States of America
– name: 1 Department of Pathology, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
Author_xml – sequence: 1
  givenname: Rajiv L.
  surname: Gaur
  fullname: Gaur, Rajiv L.
– sequence: 2
  givenname: Megan M.
  surname: Suhosk
  fullname: Suhosk, Megan M.
– sequence: 3
  givenname: Niaz
  surname: Banaei
  fullname: Banaei, Niaz
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23144722$$D View this record in MEDLINE/PubMed
BookMark eNp9UttuEzEQXaEieoE_QGCJl74k-L5eHiqVqIWVIpAgwKPl9XobR1472LtU_QP-h__gm3CaBLUV4mlGM2fOnBmd4-LAB2-K4jmCU0RK9HoVxuiVm65zeQohFRCXj4ojVBE84RiSgzv5YXGc0gpCRgTnT4pDTBClJcZHxc_ag692iAHUfT_60Id2dGqwwYPQAQW-LYMz4K0LoQX15YfJ71_gk3FGJQPOU1I34MIvldcmgQWYGedyN2VFKResB5_HZmX0kMC1HZZgrgbjB7AYGxP16EKyCdS-y4C87mnxuFMumWe7eFJ8ubxYzN5P5h_f1bPz-UQzzIeJVqViTHcaMy4qiFClm67TFRYVgazkjLW8UqJrWooo4VSIhmslKBK86XRXkpPi5ZZ3nQXI3ROTRARzxjGFKCPqLaINaiXX0fYq3sigrLwthHglVRysdkZConirOeQlw5QwKDSmDUM56USLqM5cZ7ttY9ObVuf7o3L3SO93vF3Kq_BDEioIrlgmON0RxPB9NGmQvU06P1p5E8asGzFUYViVG-irB9B_X_firqK_UvaWyIA3W4COIaVoOqntcOuILNA6iaDc-G9PLjf-kzv_5WH6YHjP_9-xPwe_4q0
CitedBy_id crossref_primary_10_1164_rccm_201406_1041LE
crossref_primary_10_1016_j_jim_2013_08_004
crossref_primary_10_1093_occmed_kqt105
crossref_primary_10_1128_JCM_02803_15
crossref_primary_10_1016_j_jim_2014_10_011
crossref_primary_10_1128_CMR_00034_13
crossref_primary_10_1016_j_diagmicrobio_2015_05_007
crossref_primary_10_1128_JCM_01627_13
crossref_primary_10_4161_hv_27657
Cites_doi 10.1097/QAI.0b013e31820b07ab
10.1038/nature04444
10.1128/CMR.00046-08
10.1016/j.immuni.2010.10.002
10.4049/jimmunol.176.5.3019
10.1371/journal.pone.0008517
10.1073/pnas.0901720106
10.1038/jid.2009.151
10.1126/science.1183021
10.1056/NEJM199612263352602
10.1084/jem.20081779
10.1093/oxfordjournals.aje.a121593
10.1016/j.tube.2011.01.001
10.1038/ni1112
10.1073/pnas.1015153108
10.1038/nm.2001
10.1073/pnas.1934678100
10.1172/JCI57235
10.7326/0003-4819-146-5-200703060-00006
10.1074/jbc.M702690200
10.1016/j.chembiol.2005.10.013
10.1038/ni712
10.1111/j.1600-065X.2008.00630.x
10.1038/nm0895-815
10.1016/j.immuni.2007.03.009
10.1371/journal.pone.0022074
10.1093/cid/cir068
10.1053/srin.2001.29315
10.1128/CMR.00027-06
10.1084/jem.20091750
10.1097/INF.0b013e318214b915
10.1084/jem.20051782
10.1093/aje/152.3.247
10.1038/ni1449
10.1038/ni1010
10.1164/ajrccm.161.supplement_3.ats600
10.1001/archderm.134.1.25
10.1172/JCI38482
ContentType Journal Article
Copyright 2012 Gaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2012 Gaur et al 2012 Gaur et al
Copyright_xml – notice: 2012 Gaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2012 Gaur et al 2012 Gaur et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0048027
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
Proquest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Agricultural Science Database


MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
Biology
DocumentTitleAlternate Immunomodulation of IGRA Enhances TB Response
EISSN 1932-6203
ExternalDocumentID 1326562401
oai_doaj_org_article_03a6dc60675243508c24b51508f8d14c
PMC3483295
2943743661
23144722
10_1371_journal_pone_0048027
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
California
GeographicLocations_xml – name: United States--US
– name: California
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RIG
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
CGR
CUY
CVF
ECM
EIF
NPM
PV9
RZL
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
PUEGO
5PM
-
02
AAPBV
ABPTK
ADACO
B0M
BBAFP
KM
ID FETCH-LOGICAL-c526t-ca7a55cfc256890119cbffc92893057655d69a8fbd41436488b6ca84186bfcf73
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Jun 05 00:11:04 EDT 2022
Wed Aug 27 01:32:33 EDT 2025
Thu Aug 21 14:13:11 EDT 2025
Fri Sep 05 07:27:16 EDT 2025
Fri Jul 25 10:10:38 EDT 2025
Thu Apr 03 06:53:43 EDT 2025
Tue Jul 01 02:04:46 EDT 2025
Thu Apr 24 23:13:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c526t-ca7a55cfc256890119cbffc92893057655d69a8fbd41436488b6ca84186bfcf73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: NB is a provisional patent holder on in vitro immunomodulation of IGRA.
Conceived and designed the experiments: RLG MMS NB. Performed the experiments: RLG MMS NB. Analyzed the data: RLG MMS NB. Contributed reagents/materials/analysis tools: RLG MMS NB. Wrote the paper: RLG NB.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0048027
PMID 23144722
PQID 1326562401
PQPubID 1436336
ParticipantIDs plos_journals_1326562401
doaj_primary_oai_doaj_org_article_03a6dc60675243508c24b51508f8d14c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3483295
proquest_miscellaneous_1151920975
proquest_journals_1326562401
pubmed_primary_23144722
crossref_citationtrail_10_1371_journal_pone_0048027
crossref_primary_10_1371_journal_pone_0048027
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-10-29
PublicationDateYYYYMMDD 2012-10-29
PublicationDate_xml – month: 10
  year: 2012
  text: 2012-10-29
  day: 29
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2012
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References JH Fritz (ref35) 2007; 26
A Cattamanchi (ref13) 2011; 56
CA Kauffman (ref37) 2007; 20
MJ Newport (ref22) 1996; 335
M Gilleron (ref26) 2006; 13
(ref1) 2010
SM Blower (ref6) 1995; 1
A Bafica (ref29) 2005; 202
LJ Abu-Raddad (ref5) 2009; 106
M Schnare (ref21) 2001; 2
E Ishikawa (ref27) 2009; 206
(ref4) 2000; 161
FJ Barrat (ref32) 2008; 223
V Herrera (ref9) 2011; 52
L Edwards (ref30) 1998; 134
A Iwasaki (ref34) 2004; 5
DL Barber (ref40) 2006; 439
(ref8) 2000; 49
GH Mazurek (ref11) 2010; 59
S Machingaidze (ref12) 2011; 30
K Honda (ref20) 2003; 100
TH Mogensen (ref17) 2009; 22
RL Coffman (ref31) 2010; 33
C von Pirquet (ref7) 1907; 52
N Banaiee (ref24) 2006; 176
S Winer (ref39) 2009; 15
SJ Huang (ref23) 2009; 129
H Bruns (ref42) 2009; 119
E Doz (ref25) 2007; 282
F Coulombe (ref28) 2009; 206
A Iwasaki (ref18) 2010; 327
M Ruhwald (ref16) 2011; 91
K Hoebe (ref19) 2003; 4
GW Comstock (ref2) 1974; 99
G Vogt (ref41) 2011; 121
D Pappagianis (ref38) 2001; 16
T Parkinson (ref33) 2008; 10
T Lahey (ref36) 2011; 6
D Menzies (ref10) 2007; 146
KA Millington (ref15) 2011; 108
RN van Zyl-Smit (ref14) 2009; 4
SA Khader (ref43) 2007; 8
E Vynnycky (ref3) 2000; 152
10933272 - Am J Epidemiol. 2000 Aug 1;152(3):247-63
17339619 - Ann Intern Med. 2007 Mar 6;146(5):340-54
10881762 - MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51
15454922 - Nat Immunol. 2004 Oct;5(10):987-95
8960473 - N Engl J Med. 1996 Dec 26;335(26):1941-9
21459676 - Tuberculosis (Edinb). 2011 May;91(3):260-7
19581406 - J Exp Med. 2009 Aug 3;206(8):1709-16
21427627 - Pediatr Infect Dis J. 2011 Aug;30(8):694-700
19381021 - J Clin Invest. 2009 May;119(5):1167-77
17617634 - J Biol Chem. 2007 Sep 7;282(36):26014-25
21911939 - J Clin Invest. 2011 Oct;121(10):3889-901
19666590 - Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13980-5
21427227 - Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5730-5
17433730 - Immunity. 2007 Apr;26(4):445-59
10764341 - Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47
17351619 - Nat Immunol. 2007 Apr;8(4):369-77
18613842 - Immunol Rev. 2008 Jun;223:271-83
16493060 - J Immunol. 2006 Mar 1;176(5):3019-27
20008526 - J Exp Med. 2009 Dec 21;206(13):2879-88
9449906 - Arch Dermatol. 1998 Jan;134(1):25-30
20577159 - MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25
14625548 - Nat Immunol. 2003 Dec;4(12):1223-9
21460320 - Clin Infect Dis. 2011 Apr 15;52(8):1031-7
21239993 - J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8
21799772 - PLoS One. 2011;6(7):e22074
4810628 - Am J Epidemiol. 1974 Feb;99(2):131-8
16365150 - J Exp Med. 2005 Dec 19;202(12):1715-24
21029960 - Immunity. 2010 Oct 29;33(4):492-503
16382236 - Nature. 2006 Feb 9;439(7077):682-7
17223625 - Clin Microbiol Rev. 2007 Jan;20(1):115-32
19633657 - Nat Med. 2009 Aug;15(8):921-9
20075244 - Science. 2010 Jan 15;327(5963):291-5
16426970 - Chem Biol. 2006 Jan;13(1):39-47
19516264 - J Invest Dermatol. 2009 Nov;129(11):2676-85
7585186 - Nat Med. 1995 Aug;1(8):815-21
20041113 - PLoS One. 2009;4(12):e8517
18228178 - Curr Opin Mol Ther. 2008 Feb;10(1):21-31
11547333 - Nat Immunol. 2001 Oct;2(10):947-50
11740825 - Semin Respir Infect. 2001 Dec;16(4):242-50
12960379 - Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10872-7
19366914 - Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents
References_xml – volume: 56
  start-page: 230
  issue: (3)
  year: 2011
  ident: ref13
  article-title: Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: A systematic review and meta-analysis
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0b013e31820b07ab
– volume: 439
  start-page: 682
  issue: (7077)
  year: 2006
  ident: ref40
  article-title: Restoring function in exhausted CD8 T cells during chronic viral infection
  publication-title: Nature
  doi: 10.1038/nature04444
– volume: 22
  start-page: 240
  issue: (2)
  year: 2009
  ident: ref17
  article-title: Pathogen recognition and inflammatory signaling in innate immune defenses
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00046-08
– volume: 33
  start-page: 492
  issue: (4)
  year: 2010
  ident: ref31
  article-title: Vaccine adjuvants: Putting innate immunity to work
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.10.002
– volume: 176
  start-page: 3019
  issue: (5)
  year: 2006
  ident: ref24
  article-title: Potent inhibition of macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.5.3019
– volume: 4
  start-page: e8517
  issue: (12)
  year: 2009
  ident: ref14
  article-title: Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0008517
– volume: 106
  start-page: 13980
  issue: (33)
  year: 2009
  ident: ref5
  article-title: Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0901720106
– volume: 129
  start-page: 2676
  issue: (11)
  year: 2009
  ident: ref23
  article-title: Imiquimod enhances IFN-γ production and effector function of T cells infiltrating human squamous cell carcinomas of the skin
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2009.151
– volume: 49
  start-page: 1
  issue: (RR-6)
  year: 2000
  ident: ref8
  article-title: Targeted tuberculin testing and treatment of latent tuberculosis infection. american thoracic society
  publication-title: MMWR Recomm Rep
– volume: 327
  start-page: 291
  issue: (5963)
  year: 2010
  ident: ref18
  article-title: Regulation of adaptive immunity by the innate immune system
  publication-title: Science
  doi: 10.1126/science.1183021
– volume: 59
  start-page: 1
  issue: (RR-5)
  year: 2010
  ident: ref11
  article-title: Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - united states, 2010
  publication-title: MMWR Recomm Rep
– volume: 335
  start-page: 1941
  issue: (26)
  year: 1996
  ident: ref22
  article-title: A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199612263352602
– volume: 206
  start-page: 1709
  issue: (8)
  year: 2009
  ident: ref28
  article-title: Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide
  publication-title: J Exp Med
  doi: 10.1084/jem.20081779
– volume: 99
  start-page: 131
  issue: (2)
  year: 1974
  ident: ref2
  article-title: The prognosis of a positive tuberculin reaction in childhood and adolescence
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a121593
– volume: 91
  start-page: 260
  issue: (3)
  year: 2011
  ident: ref16
  article-title: A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis
  publication-title: Tuberculosis
  doi: 10.1016/j.tube.2011.01.001
– volume: 5
  start-page: 987
  issue: (10)
  year: 2004
  ident: ref34
  article-title: Toll-like receptor control of the adaptive immune responses
  publication-title: Nat Immunol
  doi: 10.1038/ni1112
– volume: 108
  start-page: 5730
  issue: (14)
  year: 2011
  ident: ref15
  article-title: Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1015153108
– volume: 15
  start-page: 921
  issue: (8)
  year: 2009
  ident: ref39
  article-title: Normalization of obesity-associated insulin resistance through immunotherapy
  publication-title: Nat Med
  doi: 10.1038/nm.2001
– volume: 100
  start-page: 10872
  issue: (19)
  year: 2003
  ident: ref20
  article-title: Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1934678100
– volume: 10
  start-page: 21
  issue: (1)
  year: 2008
  ident: ref33
  article-title: The future of toll-like receptor therapeutics
  publication-title: Curr Opin Mol Ther
– volume: 121
  start-page: 3889
  issue: (10)
  year: 2011
  ident: ref41
  article-title: In vitro differentiation of human macrophages with enhanced antimycobacterial activity
  publication-title: J Clin Invest
  doi: 10.1172/JCI57235
– volume: 146
  start-page: 340
  issue: (5)
  year: 2007
  ident: ref10
  article-title: Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-146-5-200703060-00006
– volume: 282
  start-page: 26014
  issue: (36)
  year: 2007
  ident: ref25
  article-title: Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M702690200
– volume: 13
  start-page: 39
  issue: (1)
  year: 2006
  ident: ref26
  article-title: The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2005.10.013
– volume: 2
  start-page: 947
  issue: (10)
  year: 2001
  ident: ref21
  article-title: Toll-like receptors control activation of adaptive immune responses
  publication-title: Nat Immunol
  doi: 10.1038/ni712
– volume: 223
  start-page: 271
  year: 2008
  ident: ref32
  article-title: Development of TLR inhibitors for the treatment of autoimmune diseases
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.2008.00630.x
– volume: 1
  start-page: 815
  issue: (8)
  year: 1995
  ident: ref6
  article-title: The intrinsic transmission dynamics of tuberculosis epidemics
  publication-title: Nat Med
  doi: 10.1038/nm0895-815
– volume: 26
  start-page: 445
  issue: (4)
  year: 2007
  ident: ref35
  article-title: Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2007.03.009
– year: 2010
  ident: ref1
  article-title: Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response
– volume: 6
  start-page: e22074
  issue: (7)
  year: 2011
  ident: ref36
  article-title: Polyantigenic interferon-gamma responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0022074
– volume: 52
  start-page: 1031
  issue: (8)
  year: 2011
  ident: ref9
  article-title: Clinical application and limitations of interferon-γ release assays for the diagnosis of latent tuberculosis infection
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir068
– volume: 16
  start-page: 242
  issue: (4)
  year: 2001
  ident: ref38
  article-title: Serologic studies in coccidioidomycosis
  publication-title: Semin Respir Infect
  doi: 10.1053/srin.2001.29315
– volume: 20
  start-page: 115
  issue: (1)
  year: 2007
  ident: ref37
  article-title: Histoplasmosis: A clinical and laboratory update
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00027-06
– volume: 206
  start-page: 2879
  issue: (13)
  year: 2009
  ident: ref27
  article-title: Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin mincle
  publication-title: J Exp Med
  doi: 10.1084/jem.20091750
– volume: 30
  start-page: 694
  issue: (8)
  year: 2011
  ident: ref12
  article-title: The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: A systematic review and meta-analysis
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e318214b915
– volume: 202
  start-page: 1715
  issue: (12)
  year: 2005
  ident: ref29
  article-title: TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
  publication-title: J Exp Med
  doi: 10.1084/jem.20051782
– volume: 152
  start-page: 247
  issue: (3)
  year: 2000
  ident: ref3
  article-title: Lifetime risks, incubation period, and serial interval of tuberculosis
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/152.3.247
– volume: 8
  start-page: 369
  issue: (4)
  year: 2007
  ident: ref43
  article-title: IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
  publication-title: Nat Immunol
  doi: 10.1038/ni1449
– volume: 4
  start-page: 1223
  issue: (12)
  year: 2003
  ident: ref19
  article-title: Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by trif-dependent and trif-independent pathways
  publication-title: Nat Immunol
  doi: 10.1038/ni1010
– volume: 161
  start-page: S221
  year: 2000
  ident: ref4
  article-title: Targeted tuberculin testing and treatment of latent tuberculosis infection. this official statement of the american thoracic society was adopted by the ATS board of directors, july 1999. this is a joint statement of the american thoracic society (ATS) and the centers for disease control and prevention (CDC). this statement was endorsed by the council of the infectious diseases society of america. (IDSA), september 1999, and the sections of this statement
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.161.supplement_3.ats600
– volume: 52
  start-page: 675
  year: 1907
  ident: ref7
  article-title: Frequency of tuberculosis in childhood
  publication-title: J A M A
– volume: 134
  start-page: 25
  issue: (1)
  year: 1998
  ident: ref30
  article-title: Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. human PapillomaVirus
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.134.1.25
– volume: 119
  start-page: 1167
  issue: (5)
  year: 2009
  ident: ref42
  article-title: Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans
  publication-title: J Clin Invest
  doi: 10.1172/JCI38482
– reference: 7585186 - Nat Med. 1995 Aug;1(8):815-21
– reference: 19366914 - Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents
– reference: 17433730 - Immunity. 2007 Apr;26(4):445-59
– reference: 21239993 - J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8
– reference: 10933272 - Am J Epidemiol. 2000 Aug 1;152(3):247-63
– reference: 8960473 - N Engl J Med. 1996 Dec 26;335(26):1941-9
– reference: 21427627 - Pediatr Infect Dis J. 2011 Aug;30(8):694-700
– reference: 21799772 - PLoS One. 2011;6(7):e22074
– reference: 21459676 - Tuberculosis (Edinb). 2011 May;91(3):260-7
– reference: 10881762 - MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51
– reference: 4810628 - Am J Epidemiol. 1974 Feb;99(2):131-8
– reference: 14625548 - Nat Immunol. 2003 Dec;4(12):1223-9
– reference: 17223625 - Clin Microbiol Rev. 2007 Jan;20(1):115-32
– reference: 19516264 - J Invest Dermatol. 2009 Nov;129(11):2676-85
– reference: 19581406 - J Exp Med. 2009 Aug 3;206(8):1709-16
– reference: 19381021 - J Clin Invest. 2009 May;119(5):1167-77
– reference: 19666590 - Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13980-5
– reference: 18613842 - Immunol Rev. 2008 Jun;223:271-83
– reference: 20577159 - MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25
– reference: 21460320 - Clin Infect Dis. 2011 Apr 15;52(8):1031-7
– reference: 11740825 - Semin Respir Infect. 2001 Dec;16(4):242-50
– reference: 21911939 - J Clin Invest. 2011 Oct;121(10):3889-901
– reference: 17351619 - Nat Immunol. 2007 Apr;8(4):369-77
– reference: 16426970 - Chem Biol. 2006 Jan;13(1):39-47
– reference: 11547333 - Nat Immunol. 2001 Oct;2(10):947-50
– reference: 12960379 - Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10872-7
– reference: 19633657 - Nat Med. 2009 Aug;15(8):921-9
– reference: 10764341 - Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47
– reference: 20041113 - PLoS One. 2009;4(12):e8517
– reference: 15454922 - Nat Immunol. 2004 Oct;5(10):987-95
– reference: 21427227 - Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5730-5
– reference: 17339619 - Ann Intern Med. 2007 Mar 6;146(5):340-54
– reference: 16365150 - J Exp Med. 2005 Dec 19;202(12):1715-24
– reference: 16382236 - Nature. 2006 Feb 9;439(7077):682-7
– reference: 9449906 - Arch Dermatol. 1998 Jan;134(1):25-30
– reference: 20008526 - J Exp Med. 2009 Dec 21;206(13):2879-88
– reference: 17617634 - J Biol Chem. 2007 Sep 7;282(36):26014-25
– reference: 20075244 - Science. 2010 Jan 15;327(5963):291-5
– reference: 21029960 - Immunity. 2010 Oct 29;33(4):492-503
– reference: 18228178 - Curr Opin Mol Ther. 2008 Feb;10(1):21-31
– reference: 16493060 - J Immunol. 2006 Mar 1;176(5):3019-27
SSID ssj0053866
Score 2.1215346
Snippet Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine...
Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as...
Background Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as...
SourceID plos
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e48027
SubjectTerms Adaptive immunity
Adjuvants
Adolescent
Adult
Aged
Aminoquinolines - immunology
Aminoquinolines - pharmacology
Antigen-presenting cells
Antigens
Assaying
Biology
Blood
Cell activation
Costimulator
Cytokines
Epidemics
Female
Humans
Imiquimod
Immune response
Immune system
Immunity
Immunomodulation
Immunotherapy
In vitro methods and tests
Infections
Infectious diseases
Inflammation
Innate immunity
Interferon
Interferon-gamma - blood
Interferon-gamma - immunology
Interferon-gamma Release Tests - methods
Laboratories
Latent Tuberculosis - blood
Latent Tuberculosis - diagnosis
Latent Tuberculosis - immunology
Ligands
Lipopolysaccharides
Lipopolysaccharides - immunology
Lipopolysaccharides - pharmacology
Lymphocytes
Lymphocytes T
Male
Medicine
Middle Aged
Mycobacterium tuberculosis
Poly (I:C)
Poly I-C - immunology
Poly I-C - pharmacology
Polyinosinic:polycytidylic acid
Proteins
Receptors
Reproducibility of Results
Sensitivity
Sensitivity and Specificity
Sensitivity enhancement
Studies
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Toll-like receptors
Toll-Like Receptors - agonists
Toll-Like Receptors - immunology
Tuberculosis
Viral infections
Young Adult
γ-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQ5a-hLTISBzikzZ_t-Fiqrlokemql3iL_RY1UnGqTgHgD3of34JmYcbyrXVSpF66xN7E9M55vvONvCPmgipwrxmyat1akVQ0xq3YWeW9dyXQJ9hfInr9e8vPr6ssNu9ko9YU5YTM98Lxwx1mpuDUcgW0Brj2rTVFphizmbW3zyuDum8lsFUzNezBYMefxolwp8uMol6P73rujcI0aq8hsOKLA14_8pnf98BDW_DdlcsMHLZ6TZxE80pN50LvkifMvyG40z4F-jBzSn16SXxeefu_GZU87vADSf-ttrNNF-5Yq-gPL4tKQtU4vFpfpn98Uq6eAS6OAptVP6vytCi-9oni2D60hlxYedJ4Ok8bjm4HiKS6F98Jw6ThptzQTTK3DTnOOl39FrhdnV6fnaSy6kBpW8DE1SoDsTGsAC9V4L1Ua3bZGQmAGWwOIjlkuVd1qWwHU4mD_mhtVV3nNdWtaUb4mOx6WeY_QzMJ2IZ223JWVLoSUSgjhBATzshZaJ6RcSaAxkZEcC2PcNeFvNgGRybyuDcqtiXJLSLr-1f3MyPFI_88o3HVf5NMOD0DLmqhlzWNalpA9VI3VBwb4XAFIGOBQnpCDlbo83Px-3QyWiyJT3vUT9AGwJUF3BUvIm1m71oME1F0hjWdCxJbebc1iu8V3t4EdvKxw1dnb_zHtffIUAGKBvrqQB2RnXE7uEEDYqN8Fe_sLwVkyRg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3LbtQwFLWgSIgNouXRQIuMxAIWaScvO15VbdWhg2gXaArdRX6lHWlwhklmwR_wP_wH39R7Pc7QQRVsY-fl-zrXj3MJeSvThMmiMHFSGx7nJeSsyhrkvbVZoTKwP0_2fHbOTi_yj5fFZZhwa8O2yt4nekdtGo1z5PuQNQH0gPiTHMy-x1g1CldXQwmN--RBApEG9bwcfug9MdgyY-G4XMaT_SCdvVnj7J4_TI21ZG6FI8_ajyyn06a9C3H-vXHyViQaPiGPA4Skh0uZb5J71m2Rh2dhkXyLbAZ7bem7QCr9_in5OXL0y6SbN3SEJ0Kab40JhbtoU1NJv2KdXHqE29jpaHge__5FP0NEghhHQYLyBz1x19I_dEyP7XQKrX5zLVyYOAruB-dzWorTuvQT4FfX0fFC2blewF9OWjoKm77cM3IxPBkfn8ahCkOsi5R1sZYchKlrDeCoxIOqQqu61gIyNfAVIMvCMCHLWpkcsBcDh6CYlmWelEzVuubZc7LhYMS3CR0Y8B_CKsNslquUCyE555ZDdi9KrlREsl4YlQ4U5VgpY1r5dTcOqcpyiCsUYRVEGJF4dddsSdHxn_5HKOdVXyTY9hea-VUV7LUaZJIZzTCfSgFRDkqd5qpA8vy6NEmuI7KNWtK_oK3-6GdEdnrNubv5zaoZTBnXZ6SzzQL6APoS6UDwIiIvloq2-kiA4TnyekaEr6ng2l-st7jJtacLz3Ic9eLlvz_rFXkEWDDFsJyKHbLRzRd2F_BWp157o7oBEbcswQ
  priority: 102
  providerName: ProQuest
Title In Vitro Immunomodulation of a Whole Blood IFN-γ Release Assay Enhances T Cell Responses in Subjects with Latent Tuberculosis Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/23144722
https://www.proquest.com/docview/1326562401
https://www.proquest.com/docview/1151920975
https://pubmed.ncbi.nlm.nih.gov/PMC3483295
https://doaj.org/article/03a6dc60675243508c24b51508f8d14c
http://dx.doi.org/10.1371/journal.pone.0048027
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELb2ceGCWF4bWCojcYBDqsZJ7OSAEK1atoit0KqF3iLbcXYrhWRpUon9B_wf_ge_iRnXrSgqQlxyiJ2HPTOeb_z4hpAXkgVcxnHuB0Uu_CiBmFWZHHlvTRirEOzPkj1fTPj5LHo_j-cHZJOz1XVgsze0w3xSs2XZ_fb19g0Y_GubtUEEm4e6N3VluvaQNBOH5Bh8E8dw7CLariuAddvVS0QtPme90B2m-9tbdpyV5fRHDtSybvbh0T-3Vf7mp0b3yF0HMOnbtUackANT3ScnzoQb-tLxTL96QL6PK_pp0S5rOsZDIvWXOne5vGhdUEk_Y-pc2sed7XQ8mvg_f9BLcFLg9igIVd7SYXUt7UundGDKEkrtflu4sagojEg4xdNQnOmlHwDSVi2drpRZ6hU0bdHQsdsHVj0ks9FwOjj3XWIGX8eMt76WAuSrCw14KcGzq6lWRaFTCN5g-ADxxjlPZVKoPAI4xmGMUFzLJAoSrgpdiPAROaqgm08J7eUwpKRG5dyEkWIiTaUQwggI-NNEKOWRcCOBTDvWckyeUWZ2KU5A9LLu1wzlljm5ecTfPnWzZu34R_0-CndbFzm37Y16eZU5E856oeS55hhiMQCZvUSzSMXIp18keRBpj5yiamw-0MDnGKBlgEyBR8426rK_-Pm2GKwbl2xkZeoV1AFAlrJeKmKPPF5r1_YnAZlHSPXpEbGjdzut2C2pFteWQTyMsNfjJ__ZTU_JHcCLDF03S8_IUbtcmWeAyVrVIYdiLuCaDAK8jt51yHF_OPl42bGzHB1rhr8ADIk8tA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VIgEbRMujhgKDBBIs3MavGXuBEA2NYppkgVLozp2XaaRghzgR6h_wNWz4D76Je-1xaFAFq249E2c893XuzH0Q8lz4HhNRpF0v19wNY_BZpdFY99YEkQxA_upiz8MR6x-H70-ikw3yo82FwbDKVifWilqXCs_I98FrAugB9sd7M_vqYtcovF1tW2g0bHFkzr-By1a9Tt8BfV_4fu9w3O27tquAqyKfLVwlOCxO5QqMfYyJl4mSea4S8DyA92FtkWaJiHOpQ8ASDBhcMiXi0IuZzFXOA3jvNXI9DAKGUhR3VyEloDsYs-l5Aff2LTfszcrC7NXJ29i75oL5q7sEYFXVaVldhnD_DtS8YPl6d8htC1np24bHtsiGKbbJjaG9lN8mW1Y_VPSlLWL96i75nhb042QxL2mKGSjll1LbRmG0zKmgn7AvLz3AsHma9kbur5_0A1hAsKkUOEac08PiTNQvHdOumU5htA7mhQeTgoK6w_OjiuIxMh0AXi4WdLyUZq6W8JWTiqY2yKy4R46vhD73yWYBO75DaEeDvkqM1MwEofR5kgjOueFG-knMpXRI0BIjU7YkOnbmmGb1PR8H16jZ4gxJmFkSOsRd_WrWlAT5z_wDpPNqLhb0rh-U88-Z1Q9ZJxBMK4b-mw8IthMrP5QRFuvPY-2FyiE7yCXtH1TZH3lwyG7LOZcPP1sNg-rA-yBRmHIJcwDtJX4n4ZFDHjSMtlokwP4Q64g6hK-x4NpXrI8Uk7O6PHkQ4q5HD_-9rKfkZn88HGSDdHT0iNwCHOojJPCTXbK5mC_NY8B6C_mkFjBKTq9aon8D7qlpJQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VIlVcEC0_NRRYJJDg4CZe27v2ASGaNqppGyHUQm_u_plGCnaIE6G-Ae_DjYfgmZhx1qFBFZx69W6c9c7_7sw3hDyXLOAyjo0fFEb4UQIxq7IGcW9tGKsQ5K8Bez4a8P2T6N1pfLpCfra1MJhW2erERlGbSuMZeQeiJnA9wP4EncKlRbzf7b8Zf_WxgxTetLbtNOYscmAvvkH4Vr_OdoHWLxjr7x339n3XYcDXMeNTX0sBC9WFBsOfYBFmqlVR6BSiEJADWGdseCqTQpkI_AoOzK64lkkUJFwVuhAhvPcGuSlCIVC6kt4ivQT0COeuVC8UQcdxxva4Ku12U8iNfWwumcKmYwAirI6q-ipv9--kzUtWsH-H3HbuK30757d1smLLDbJ25C7oN8i60xU1fekArV_dJd-zkn4cTicVzbAapfpSGdc0jFYFlfQT9uilO5hCT7P-wP_1g34Aawj2lQL3yAu6V57L5qXHtGdHIxhtEnvhwbCkoPrwLKmmeKRMD8F3Lqf0eKbsRM_gK4c1zVzCWXmPnFwLfe6T1RJ2fJPQrgHdlVpluA0jxUSaSiGEFVaxNBFKeSRsiZFrB4-OXTpGeXPnJyBMmm9xjiTMHQk94i9-NZ7Dg_xn_g7SeTEXwb2bB9Xkc-50Rd4NJTeaYyzHwJvtJppFKkbg_iIxQaQ9solc0v5Bnf-RDY9stZxz9fCzxTCoEbwbkqWtZjAHPL-UdVMRe-TBnNEWi4QQIEJMUY-IJRZc-orlkXJ43kCVhxHuevzw38t6StZAlvPDbHDwiNwCl5Shd8DSLbI6nczsY3D7pupJI1-UnF23QP8GpeptWw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Immunomodulation+of+a+Whole+Blood+IFN-%CE%B3+Release+Assay+Enhances+T+Cell+Responses+in+Subjects+with+Latent+Tuberculosis+Infection&rft.jtitle=PloS+one&rft.au=Gaur%2C+Rajiv+L.&rft.au=Suhosk%2C+Megan+M.&rft.au=Banaei%2C+Niaz&rft.date=2012-10-29&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=7&rft.issue=10&rft.spage=e48027&rft_id=info:doi/10.1371%2Fjournal.pone.0048027&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0048027
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon